Fatty Acids
In clinical developmentAlso known as FATTY ACID.
Recent clinical, regulatory, research and industry developments relating to this drug.
Metabolic control of luteinizing hormone-responsive ovarian steroidogenesis.
Integrative Omics Reveals the Metabolic Patterns During Oocyte Growth.
Fatty acid oxidation in immune function.
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment.
PFOS-elicited metabolic perturbation in liver and fatty acid metabolites in testis of adult mice.
Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Thyroid hormone increases fatty acid use in fetal ovine cardiac myocytes.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences7
- The Journal of clinical investigation3
- Molecules (Basel, Switzerland)2
- Nutrients2
- Animal : an international journal of animal bioscience1
- British journal of cancer1
- Wang Y2
- Abdel-Wahab O1
- Abel U1
- Acampora L1
- Adachi H1
- Ali A1
- Allen-Vercoe E1
- Allgeier C1
- Beth Israel Deaconess Medical Center2
- Imperial College London2
- 1st Neurology Clinic1
- Aarhus University1
- Allegheny General Hospital1
- Barts Cancer Institute1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 16 of the same disease areas as Fatty Acids in the shared literature.
Studied across 12 of the same disease areas as Fatty Acids in the shared literature.
Studied across 9 of the same disease areas as Fatty Acids in the shared literature.
Studied across 8 of the same disease areas as Fatty Acids in the shared literature.
Studied across 7 of the same disease areas as Fatty Acids in the shared literature.
Studied across 6 of the same disease areas as Fatty Acids in the shared literature.
Studied across 4 of the same disease areas as Fatty Acids in the shared literature.
Studied across 3 of the same disease areas as Fatty Acids in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials